NKGenBiotech,Inc.

This profile gathers the share dealings of NKGenBiotech,Inc. in 엔케이젠바이오텍코리아. Between 12 July 2021 and 22 April 2026, the trades on record add up to 13 filings.

Purchases make up the whole of the open-market record (3 purchases, €14.6M). No amount is published for 2 filings, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price.

The latest filing, published on 22 April 2026, reports a transaction in 엔케이젠바이오텍코리아. The latest purchase dates back some time: it was published 487 days ago, on 10 July 2025. Between a trade and the moment it shows up on DART (FSS), the median delay is 6 days. That lag is the time during which only the insider knows about the trade. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.